← Back to Search

rtACS treatment for Open-Angle Glaucoma

Phase 1 & 2
Waitlist Available
Led By Jeffrey L Goldberg, MD PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Participant must be at least 18.
* Participant must has the ability to comply with the requirements of the study and complete the schedule of events (SOE).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

The purpose of the study is to evaluate the efficacy, transorbital alternating current stimulation (rtACS) using the EYETRONIC for the treatment in patients with glaucoma.

Eligible Conditions
  • Open-Angle Glaucoma
  • Glaucoma

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean Deviation (MD)
Pointwise Linear Regression (PLR)
Visual Field Index (VFI)
Secondary study objectives
Best Corrected Visual Acuity
Ganglion Cell Layer
OCT-Angiography
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: rtACS treatmentExperimental Treatment1 Intervention
Participants will receive 10 days of rtACS treatment in office.
Group II: ShamPlacebo Group1 Intervention
Participants will be wearing device but no stimulation will occur for 10 treatments in office.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,470 Previous Clinical Trials
17,501,747 Total Patients Enrolled
Neuromodtronic, GmbHUNKNOWN
Jeffrey L Goldberg, MD PhDPrincipal InvestigatorStanford University
3 Previous Clinical Trials
125 Total Patients Enrolled
~20 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top